Posts Tagged ‘Alzheimers-treatment’
Systematic review finds more clinical harm than benefits in Alzheimer’s “treatments” lecanemab, aducanumab, and donanemab
Study questions benefit of new Alzheimer’s drug (UGA Today): Last summer, the U.S. Food and Drug Administration fully approved the first drug shown to slow the progress of Alzheimer’s. But new research from the University of Georgia suggests that patients and caregivers may not experience any benefit from the drug in their daily lives. The drug, Leqembi,…
Read MoreAlzheimer’s & Dementia researchers challenge FDA’s approval of Aduhelm given lack of evidence for beta-amyloid as a marker
Doctors Blast Biogen Alzheimer Approval as ‘Regulatory Failure’ (Bloomberg): Top researchers who advised the U.S. Food and Drug Administration on Biogen Inc.’s Alzheimer’s drug blasted the agency for approving it, calling the decision a “regulatory failure” that is “at odds with the evidence.”
Read MoreRethinking Alzheimer’s Prevention and Treatment: The Cognitive Shop/ Brain Fitness Center
Editor’s note: Kenneth S. Kosik, MD, and Ellen Clegg, authors of a recent book on Alzheimer’s Disease prevention and treatment, forcefully propose a new framework and model for brain care: What about setting up “cognitive shops” as “a sort of one-stop shopping for everything from Alzheimer’s disease prevention to guided care for mild or moderate…
Read MoreThe Best Memory Tests: Mini-Mental and Beyond (Alzheimer’s Action Plan)
The Alzheimer’s Alzheimer’s Disease Action Plan — The Experts’ Guide to the Best Diagnosis and Treatment for Memory Problems, recently released in paperback. Dr. Murali Doraiswamy, one of the authors and leading Alzheimer’s expert.
Read More